Navigation Links
Targeting cholesterol to fight deadly brain cancers
Date:9/15/2011

Blocking the uptake of large amounts of cholesterol into brain cancer cells could provide a new strategy to battle glioblastoma, one of the most deadly malignancies, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.

The study, done in cells lines, mouse models and analysis of tissue from brain cancer patients, uncovered a novel mechanism by which the most commonly activated oncogene, the mutated epidermal growth factor receptor (EGFR), overcomes normal cell regulatory mechanisms to feed large amounts of cholesterol to the brain cancer cells, said Dr. Paul Mischel, a professor of pathology and laboratory medicine and molecular and medical pharmacology, a Jonsson Cancer Center researcher and senior author of the study.

The study appears Sept. 15 in Cancer Discovery, the newest peer-reviewed journal of the American Association for Cancer Research. It shows that EGFRvIII, common in glioblastoma, promotes the import of cholesterol into cancer cells by up-regulating its cellular receptor, the LDL receptor, promoting rapid tumor growth and survival.

There are at least three ways by which cells normally tightly control their cholesterol levels - synthesis, import and efflux, or pumping out the cholesterol, Mischel said.

"Our study found that the mutant EGFR hijacks this system, enabling cancer cells to import large amounts of cholesterol through the LDL receptor," Mischel said. "This study identifies the LDL receptor as a key regulator of cancer cell growth and survival, and as a potential drug target."

Mischel and his colleagues hypothesized that targeting the LDL receptor for destruction could result in strong anti-tumor activity against glioblastoma. They showed that a drug that activates the nuclear Liver X Receptor, a critical regulator of intracellular cholesterol that ensures appropriately balanced levels, degraded the LDL receptor in tumor cells bearing EGFR mutations, potently killing
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Targeting innate immunity in malaria
2. Targeting PTEN may prevent skin cancer
3. Targeting the Ewing sarcoma family of tumors
4. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
5. Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables
6. NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB
7. Targeting top 911 callers can trim cost, improve patient care
8. Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial
9. New program targeting whole-person health care gets major grant
10. Targeting nicotine receptors to treat cognitive impairments in schizophrenia
11. Scientists announce new advance with potential for future cancer targeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Washington, PA (PRWEB) May 29, 2015 ... ” quiz-based learning in 14 medical specialties, now offers ... includes a wide spectrum of rheumatology disorders ranging from ... Alfred Saint Jacques, editorial director of MDLinx, and Caroline ... excited about the impact it will have on the ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 The ... greatly in the last decade. New and more efficient methods ... hair available to balding patients. One of the most cutting ... Parsa Mohebi Hair Restoration is the technique of extracting hair ... to scalp transplants are performed to correct male pattern ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and her son, yet ... does no wrong. , It’s fitting, then, that her new ... “God Does No Wrong.” It focuses on what happens when ... , “My story has a positive message about channeling the ... something healing,” Howse said. , “God Does No Wrong” immortalizes ...
(Date:5/29/2015)... May 29, 2015 World Patent Marketing, ... announces that it has signed a 10 year licensing ... that aims to let people learn about any topic ... time. , "This is an exciting day for World ... Scott J. Cooper, CEO and Creative Director of World ...
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 Mediaplanet ... the “beauty of protection”. Skin Health is a ... Today within the markets of New York, Los Angeles, ... estimated 750,000 readers. Its digital counterpart will reach a ... hubs. To read more the Skin Health campaign and ...
Breaking Medicine News(10 mins):Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Turning grief from a child’s passing into virtue 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2
... Program Offered to Local Seniors, SAN FRANCISCO, ... have,the opportunity to exercise their brains through the ... through a partnership with San,Francisco-based Posit Science. The ... mental processing, memory and other cognitive functions,with participants ...
... rhythms, helped with depression, agitation in elderly , , TUESDAY, ... lighting may ease some of the behavioral problems associated ... melatonin, a hormone which seems to play a role ... at night. , Both strategies could greatly improve quality ...
... Lose $96.7 Million in Economic Activity, $45.5 Million,in ... American Health Care,Association (AHCA) today released a new ... million (national) Medicare Part A,nursing home funding cuts ... essential health benefits in the year ahead, but ...
... CHAPEL HILL, N.C., June 10 Highly ... turnover and boost,corporate performance reside in less ... member-driven research study conducted by Best Practices,LLC,s ... satisfaction and engagement metrics and,ensure employees know ...
... old Mark Rohner of,London, Ohio, the amputation of his right ... a medical drama. During the operation in 2006, the saw,the ... knee, broke,while cutting into the bone. Like in the best ... a neighboring hospital for a,replacement saw to complete the job., ...
... doctors with patients of both races still showed disparities in ... shows that black patients with diabetes tend to fare worse ... doctor. , In other words, the gap can,t be explained ... disparities in diabetes care appear to be more the result ...
Cached Medicine News:Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 2Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 3Health News:Adding Light Eases Behavioral Problems of Dementia 2Health News:Adding Light Eases Behavioral Problems of Dementia 3Health News:New PA Economic Study: Bush Medicare Cuts Compound State Medicaid Crisis 2Health News:Best-in-Class Engagement Programs: Employees See Link Between Quality & Performance 2Health News:Gunther von Hagens' BODY WORLDS Exhibitions Welcome Specimens From World's First Living Body Donor for Plastination 2Health News:Gunther von Hagens' BODY WORLDS Exhibitions Welcome Specimens From World's First Living Body Donor for Plastination 3Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 2Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 3
(Date:5/29/2015)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the ... commercializing proven cancer therapies in new orphan drug ... American Association of Cancer Research (AACR) Advances in ... for its lead product candidate VAL-083 ...
(Date:5/29/2015)... prostate surgeon and New York Urologist, Dr. David Samadi ... Fusion-Guided Biopsy for detecting aggressive prostate cancer . ... Lenox Hill Hospital is the only center using the revolutionary ... City . We,ve seen tremendous improvement in detecting and ... an MRI makes for a much more accurate diagnosis, especially ...
(Date:5/28/2015)... and HOUSTON , May 28, ... (TSX-V: EPI) today reported financial results for the second quarter ... unless specified otherwise, are expressed in Canadian dollars and in ... Summary Results ESSA recorded a net loss ... months ended March 31, 2015 (Q2-2015), compared to a net ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 31, 2010 ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse = function(data) ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var ...
... Inc. (Nasdaq: BNVI, BNVID) announced today that it has ... Administration (FDA) regarding the Company,s Chemistry, Manufacturing and Controls ... FDA indicated its agreement with Bionovo,s plan. This agreement ... to pivotal phase 3 clinical testing. Menerba ...
Cached Medicine Technology:Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 2Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 3Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 4Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 5Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 6Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 7Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 8Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials 9Bionovo Receives Positive Guidance from FDA on Menerba® 2Bionovo Receives Positive Guidance from FDA on Menerba® 3
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
... Stepper, a lightweight, easy-to-use repeater ... up to 45 times in ... Stepper handle is adapted for ... a dispensing volume range from ...
... The Repeater Plus, a handheld manual dispenser, ... time on long series pipetting. Its increased ... support for research tasks, and its smooth ... repetitive work. The nine Combitips allow a ...
... of its kind, the noncontact EnSite ... cardiac electrical information, translating it into ... electrodes, this unique tool simplifies ablation ... points of electrical data in a ...
Medicine Products: